his workshop will provide a comprehensive look at the challenges and solutions for sharing sensitive behavioral health and SUD treatment information in compliance with 42 CFR Part 2. The session will explore the critical role of patient consent as the foundation for the exchange of sensitive data, focusing on strategies that balance patient privacy with the need for data availability for treatment, payment, and operations (TPO).
Attendees will learn about policy alignment, technology, and workflow integration necessary to effectively operationalize consent models that provide this balance. The workshop will also highlight innovative approaches and real-world examples, including the implementation of successful cross-sector partnerships and technical assistance initiatives. The final goal is to equip participants with the knowledge to build and maintain trust among stakeholders and implement replicable models for compliant, large-scale data sharing.
2). Align policies, technology, and workflows to operationalize patient consents and to enable interoperability, support patient privacy, and facilitate regulatory compliance.
3). Analyze and apply lessons learned from successful public-private partnerships and interdisciplinary technical assistance initiatives, using the CRISP DC model as a case study.
4). Develop strategies for establishing and maintaining trust and alignment among diverse stakeholders to promote the adoption of HIEs and the sharing of sensitive data.
Mohammad Jafari, Ph.D., MBA, Independent Subject Matter Expert, Independent
Stephanie Brown, MPH, ML, President & Executive Director, CRISP DC
Helen Oscislawski, Esq., Founder & Managing Partner, Attorneys at Oscislawski LLC
Jennifer D'angelo, Chief Operating Officer & Executive VP of Healthcare Division, New Jersey Innovation Institute